Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-05-13 4:05 pm Sale | 13D | EFFECTOR THERAPEUTICS INC EFTR | Carlyle Group Inc. CG | 193,195 4.100% | -4,636,696 (-96.00%) | View |
| 2024-02-14 3:48 pm Purchase | 13G | EFFECTOR THERAPEUTICS INC EFTR | PFIZER INC PFE | 2,243,850 3.470% | 2,243,850 (New Position) | View |
| 2024-02-14 09:48 am Unchanged | 13G | EFFECTOR THERAPEUTICS INC EFTR | SECTORAL ASSET MANAGEMENT INC | 2,382,644 3.700% | 0 (Unchanged) | View |
| 2024-02-09 8:14 pm Sale | 13G | EFFECTOR THERAPEUTICS INC EFTR | SR ONE CAPITAL MANAGEMENT LLC | 0 0.000% | -6,822,114 (Position Closed) | View |
| 2024-02-05 4:15 pm Unchanged | 13G | EFFECTOR THERAPEUTICS INC EFTR | Altitude Life Science Ventures Fund II L.P. | 2,826,350 4.400% | 0 (Unchanged) | View |
| 2023-11-22 4:16 pm Sale | 13D | EFFECTOR THERAPEUTICS INC EFTR | COLUMN GROUP II LP | 0 0.000% | -4,091,734 (Position Closed) | View |
| 2023-09-15 4:05 pm Sale | 13D | EFFECTOR THERAPEUTICS INC EFTR | COLUMN GROUP II LP | 4,091,734 6.600% | -217,595 (-5.05%) | View |
| 2023-08-18 4:16 pm Unchanged | 13D | EFFECTOR THERAPEUTICS INC EFTR | Carlyle Group Inc. CG | 4,829,891 7.800% | 0 (Unchanged) | View |
| 2023-03-07 5:25 pm Purchase | 13G | EFFECTOR THERAPEUTICS INC EFTR | Altitude Life Science Ventures Fund II L.P. | 2,826,350 6.700% | 2,826,350 (New Position) | View |
| 2023-02-14 06:33 am Unchanged | 13G | EFFECTOR THERAPEUTICS INC EFTR | Empyrean Capital Partners LP | 0 0.000% | 0 (Unchanged) | View |
| 2023-02-13 3:06 pm Sale | 13G | EFFECTOR THERAPEUTICS INC EFTR | SECTORAL ASSET MANAGEMENT INC | 2,382,644 5.700% | -100 (-0.00%) | View |
| 2022-08-18 8:04 pm Purchase | 13D | EFFECTOR THERAPEUTICS INC EFTR | US VENTURE PARTNERS X LP | 4,480,578 10.800% | 4,480,578 (New Position) | View |
| 2022-08-18 7:54 pm Sale | 13D | EFFECTOR THERAPEUTICS INC EFTR | US VENTURE PARTNERS X LP | 0 0.000% | -4,822,114 (Position Closed) | View |
| 2022-08-11 4:55 pm Purchase | 13D | EFFECTOR THERAPEUTICS INC EFTR | Carlyle Group Inc. CG | 4,829,891 11.700% | 4,829,891 (New Position) | View |
| 2022-02-14 4:04 pm Purchase | 13G | EFFECTOR THERAPEUTICS INC EFTR | PFIZER INC PFE | 2,243,850 5.560% | 2,243,850 (New Position) | View |
| 2022-02-11 8:35 pm Purchase | 13G | EFFECTOR THERAPEUTICS INC EFTR | SR ONE CAPITAL MANAGEMENT LLC | 6,822,114 16.900% | 6,822,114 (New Position) | View |
| 2022-02-11 6:32 pm Unchanged | 13G | EFFECTOR THERAPEUTICS INC EFTR | Beryl Capital Management LLC | 0 0.000% | 0 (Unchanged) | View |
| 2022-02-11 09:18 am Purchase | 13G | EFFECTOR THERAPEUTICS INC EFTR | SECTORAL ASSET MANAGEMENT INC | 2,382,744 5.900% | 2,382,744 (New Position) | View |
| 2022-01-31 4:16 pm Unchanged | 13G | EFFECTOR THERAPEUTICS INC EFTR | Linden Capital L.P. | 0 0.000% | 0 (Unchanged) | View |
| 2021-09-13 06:23 am Purchase | 13D | EFFECTOR THERAPEUTICS INC EFTR | US VENTURE PARTNERS X LP | 4,822,114 11.900% | 4,822,114 (New Position) | View |